AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Johns Hopkins University
Persons infected with HIV-1 could benefit from receiving a vaccine to protect against a bacteria, Haemophilus influenzae type b (Hib), that often causes serious infections such as pneumonia, according to a report by Johns Hopkins investigators in the December 26, 1991, issue of the New England Journal of Medicine.
The Hib vaccine should be given in the early stages of HIV infection, if possible, because patients in later stages of HIV infection do not respond as well, says Mark C. Steinhoff, M.D., of the Center for Immunization Research at Johns Hopkins School of Public Health. The vaccine is currently licensed but used primarily …